Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Induction chemotherapy before chemoradiotherapy for locally recurrent rectal cancer
NL-OMON21546Phase 3Recruiting
- Sponsor
- ZonMw
- Start
- Nov 2020
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of capecitabine, oxaliplatin, fluorouracil, folinic acid and irinotecan in rectal cancer, sponsored by ZonMw. Started Nov 2020; status: recruiting.
02
Drugs
capecitabineoxaliplatinfluorouracilfolinic acidirinotecan
03
Conditions
rectal cancer
Beyond the preview
Go deeper on NL-OMON21546.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON21546.